FAKTOR OPTIONSSCHEIN - BOSTON SCIENTIFIC | Market Closed - Deutsche Boerse AG 03:50:23 2024-07-05 pm EDT | ||
| 245.4 EUR | +1.76% |
|
| Current month | -4.05% | ||
| 1 month | +1.89% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BOSTON SCIENTIFIC CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-07-05 | 245.4 | +1.76% |
| 24-07-04 | 241.2 | +0.82% |
| 24-07-03 | 239.2 | -2.96% |
| 24-07-02 | 246.5 | +0.23% |
| 24-07-01 | 245.9 | -3.84% |
Delayed Quote Deutsche Boerse AG
Last update July 05, 2024 at 03:50 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BOSTON SCIENTIFIC CORPORATION |
| Issuer | 
BNP Paribas
|
| WKN | PC4BSX |
| ISIN | DE000PC4BSX2 |
| Date issued | 2022-11-04 |
| Strike | 76.11 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 50 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 267.9 € |
|---|---|
| Lowest since issue | 46.89 € |
| Spread | 1.93 € |
| Spread % | 0.79% |
Company Profile
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:
- cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%);
- endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ;
- neuromodulation (2%).
The United States account for 59.2% of net sales.
Sector
-
Ratings for Boston Scientific Corporation
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Boston Scientific Corporation
Sell
Buy
Mean consensus
BUY
Number of Analysts
32
Last Close Price
76.4
USD
Average target price
82.71
USD
Spread / Average Target
+8.27%
- Stock Market
- Certificates
- Certificat
